☰

Scott C. Bresler, Ph.D. - Publications

Affiliations: 
2011 University of Pennsylvania, Philadelphia, PA, United States 
Area:
Biochemistry, General Biophysics
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Zahn J, Chan MP, Wang G, Patel RM, Andea AA, Bresler SC, Harms PW. Altered RB, p16, or p53 expression is specific for porocarcinoma relative to poroma. Journal of Cutaneous Pathology. PMID 31012122 DOI: 10.1111/Cup.13480  0.352
2016 Bresler SC, Min L, Rodig SJ, Walls AC, Xu S, Geng S, Hodi FS, Murphy GF, Lian CG. Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 27918555 DOI: 10.1038/Labinvest.2016.126  0.411
2016 Bresler SC, Padwa BL, Granter SR. Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome). Head and Neck Pathology. PMID 26971503 DOI: 10.1007/S12105-016-0706-9  0.318
2014 Bresler SC, Weiser DA, Huwe PJ, Park JH, Krytska K, Ryles H, Laudenslager M, Rappaport EF, Wood AC, McGrady PW, Hogarty MD, London WB, Radhakrishnan R, Lemmon MA, Mossé YP. ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma. Cancer Cell. 26: 682-94. PMID 25517749 DOI: 10.1016/J.Ccell.2014.09.019  0.629
2013 Huwe PJ, Bresler S, Park J, Lemmon M, Radhakrishnan R. Understanding Kinase Activation of ALK in Neuroblastoma Patients Biophysical Journal. 104: 662a. DOI: 10.1016/J.Bpj.2012.11.3654  0.618
2012 Carpenter EL, Haglund EA, Mace EM, Deng D, Martinez D, Wood AC, Chow AK, Weiser DA, Belcastro LT, Winter C, Bresler SC, Vigny M, Mazot P, Asgharzadeh S, Seeger RC, et al. Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma. Oncogene. 31: 4859-67. PMID 22266870 DOI: 10.1038/Onc.2011.647  0.645
2012 Carpenter EL, Haglund EA, Mace EM, Deng D, Martinez D, Wood AC, Chow AK, Weiser DA, Belcastro LT, Winter C, Bresler SC, Vigny M, Mazot P, Asgharzadeh S, Seeger RC, et al. Erratum: Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma Oncogene. 31: 4888-4888. DOI: 10.1038/Onc.2012.208  0.57
2011 Bresler SC, Wood AC, Haglund EA, Courtright J, Belcastro LT, Plegaria JS, Cole K, Toporovskaya Y, Zhao H, Carpenter EL, Christensen JG, Maris JM, Lemmon MA, Mossé YP. Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma. Science Translational Medicine. 3: 108ra114. PMID 22072639 DOI: 10.1126/Scitranslmed.3002950  0.647
2011 Bresler SC, Wood A, Haglund E, Christensen J, Maris JM, Lemmon MA, Mosse YP. Abstract 4685: Mechanistic guidance of ALK inhibition for the treatment of neuroblastoma Cancer Research. 71: 4685-4685. DOI: 10.1158/1538-7445.Am2011-4685  0.651
Show low-probability matches.